AU5996996A - Al/fe-treatment of a protein solution, followed by membrane concentration - Google Patents

Al/fe-treatment of a protein solution, followed by membrane concentration

Info

Publication number
AU5996996A
AU5996996A AU59969/96A AU5996996A AU5996996A AU 5996996 A AU5996996 A AU 5996996A AU 59969/96 A AU59969/96 A AU 59969/96A AU 5996996 A AU5996996 A AU 5996996A AU 5996996 A AU5996996 A AU 5996996A
Authority
AU
Australia
Prior art keywords
protein solution
treatment
followed
membrane concentration
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59969/96A
Other languages
English (en)
Inventor
Mads Aage Laustsen
Niels-Viktor Nielsen
Torben Kjaarsgaard Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5996996A publication Critical patent/AU5996996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU59969/96A 1995-06-02 1996-05-31 Al/fe-treatment of a protein solution, followed by membrane concentration Abandoned AU5996996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK62695 1995-06-02
DK626/95 1995-06-02
PCT/DK1996/000229 WO1996038469A1 (en) 1995-06-02 1996-05-31 Al/Fe-TREATMENT OF A PROTEIN SOLUTION, FOLLOWED BY MEMBRANE CONCENTRATION

Publications (1)

Publication Number Publication Date
AU5996996A true AU5996996A (en) 1996-12-18

Family

ID=8095720

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59969/96A Abandoned AU5996996A (en) 1995-06-02 1996-05-31 Al/fe-treatment of a protein solution, followed by membrane concentration

Country Status (9)

Country Link
EP (1) EP0828753B1 (enExample)
JP (1) JPH11511118A (enExample)
CN (1) CN1114613C (enExample)
AT (1) ATE235506T1 (enExample)
AU (1) AU5996996A (enExample)
DE (1) DE69626976T2 (enExample)
DK (1) DK0828753T3 (enExample)
IN (1) IN181859B (enExample)
WO (1) WO1996038469A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2810667B1 (fr) * 2000-06-23 2004-09-03 Warner Lambert Co Procede d'isolement et de purification d'une proteine, et proteine obtenue
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
ATE510023T1 (de) 2001-02-21 2011-06-15 Verenium Corp Enzyme mit alpha-amylase-aktivität und verfahren zu deren verwendung
US20030013172A1 (en) * 2001-05-14 2003-01-16 Joel Gerendash Novel methods of enzyme purification
EP1412384B1 (en) 2001-06-28 2007-12-26 Novo Nordisk A/S Stable formulation of modified glp-1
CN100487114C (zh) * 2001-12-11 2009-05-13 诺维信公司 从发酵液收获晶体
US7118891B2 (en) 2001-12-11 2006-10-10 Novozymes A/S Crystal harvest from fermentation broth
AU2004229313B2 (en) 2003-03-06 2010-08-19 Basf Enzymes Llc Amylases, nucleic acids encoding them and methods for making and using them
EP1633391B1 (en) 2003-06-03 2011-10-19 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
BRPI0410972C1 (pt) 2003-06-03 2021-05-25 Novo Nordisk As método para aumentar a vida de armazenagem de uma composição farmacêutica, composição farmacêutica, e, método para tratamento de hiperglicemia
DK3300721T4 (da) 2003-11-20 2025-03-03 Novo Nordisk As Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger
PL1789434T3 (pl) 2004-08-31 2014-07-31 Novo Nordisk As Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek
CN106137952B (zh) 2004-11-12 2020-11-17 诺和诺德公司 促胰岛素肽的稳定制剂
CA2620193C (en) * 2005-09-15 2016-02-16 Wyeth Separation of protein from impurities using salts
MX2009006782A (es) 2006-12-21 2009-09-21 Verenium Corp Amilasas y glucoamilasas, acidos nucleicos que las codifican y metodos para formarlas y usarlas.
US20120252066A1 (en) * 2011-03-29 2012-10-04 Heng Meng H Methods of foam control
US20150291656A1 (en) 2012-11-01 2015-10-15 Novozymes A/S Method for removal of dna
CN105745217A (zh) 2013-11-19 2016-07-06 凯米罗总公司 减少生物技术液体的颜色的方法
TWI847306B (zh) 2017-08-24 2024-07-01 丹麥商諾佛 儂迪克股份有限公司 Ｇｌｐ-１組成物及其用途
CN108949703A (zh) * 2018-06-28 2018-12-07 大连理工大学 一种半纤维小体类似物粗提纯方法
US12146171B2 (en) 2019-06-13 2024-11-19 Basf Se Method of recovering a protein from fermentation broth using a divalent cation
BR112022013795A2 (pt) 2020-02-18 2022-09-13 Novo Nordisk As Composição farmacêutica líquida, e, kit
BR112023005111A2 (pt) 2020-09-22 2023-04-18 Basf Se Método para recuperar uma proteína de interesse de um caldo de fermentação bacteriana, e, uso de pelo menos um floculante
CN112500471B (zh) * 2020-12-22 2022-09-27 中美华世通生物医药科技(武汉)股份有限公司 一种制备高澄清度蛋白琥珀酸铁的方法
EP4565710A1 (en) 2022-08-02 2025-06-11 Basf Se Stabilized protein production process using bacillus host cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795586A (en) * 1969-08-11 1974-03-05 Pabst Brewing Co Recovery of enzymes
PL270368A1 (en) * 1987-01-30 1988-10-13 Int Minerals & Chem Corp Method for recovery of somatotropins from diluted water solutions
US4894444A (en) * 1987-07-16 1990-01-16 Merck & Co., Inc. Recovery and purification of immunogens from immunogen-alum complexes
DE3915277A1 (de) * 1989-05-10 1990-11-15 Henkel Kgaa Verfahren zur reinigung von enzymfluessigkonzentraten
DE4037530A1 (de) * 1990-11-26 1992-05-27 Henkel Kgaa Faellungsverfahren fuer exocellulaere proteine
DK91092D0 (enExample) * 1992-07-10 1992-07-10 Novo Nordisk As

Also Published As

Publication number Publication date
EP0828753B1 (en) 2003-03-26
IN181859B (enExample) 1998-10-03
DK0828753T3 (da) 2003-06-30
DE69626976D1 (de) 2003-04-30
JPH11511118A (ja) 1999-09-28
ATE235506T1 (de) 2003-04-15
WO1996038469A1 (en) 1996-12-05
CN1186498A (zh) 1998-07-01
EP0828753A1 (en) 1998-03-18
CN1114613C (zh) 2003-07-16
DE69626976T2 (de) 2004-03-04

Similar Documents

Publication Publication Date Title
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
CA2287267A1 (en) Improved methods for processing activated protein c
BR9608729A (pt) Preparação de um pó de proteína acilada
CA2217669A1 (en) Process for isolating a protein composition from a muscle source and protein composition
MY127603A (en) Method to remove citrate and aluminum from proteins
CA2224896A1 (en) Purified heat-coagulated potato protein for use in animal feed
ES2170251T3 (es) (s)-hidroxinitriloliasa de hevea brasiliensis.
AU4876196A (en) A process for the preparation of factor ix from biological sources
FI950094A0 (fi) Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi
KR960017852A (ko) 염기성 아미노산의 정제 방법
AU4944996A (en) Dna fragment encoding d-amino acid oxidase
AU5417696A (en) Substituted tetronic acids useful for treating hiv and other retroviruses
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
AU8941091A (en) Method for purifying concentrated, aqueous and used solutions of chromic acid, and solutions thereby purified
DE3270177D1 (en) Process for purifying elastase
SE9702993D0 (sv) Anti-mikrobial komposition
AU6661394A (en) Purification of fluoronucleosides
AU6695896A (en) Process for regeneration of an aqueous process liquid of the amine-oxide process
ATE328088T1 (de) Transketolase-verwandtes protein
UA8125A1 (uk) Спосіб підготовки води